Related Experiment Video
Updated: Jun 10, 2025
09:06
Isolation of Stem-like Cells from 3-Dimensional Spheroid Cultures
Published on: December 13, 2019
9.1K
Unveiling LGR5: Prostate cancer's hidden stem cell and treatment target
Yashvi Patel1, Akhilesh Prajapati1
1Department of Life Science, Biotechnology Division, School of Science, GSFC University, Vadodara, 391750, Gujarat, India.
Urologic Oncology
|October 15, 2024
Summary
This review explores Leucine-Rich Repeat-Containing G-protein Coupled Receptor 5 (LGR5) in prostate cancer. Targeting LGR5 may offer new therapies for treatment-resistant prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer recurrence is a significant clinical challenge.
- Leucine-Rich Repeat-Containing G-protein Coupled Receptor 5 (LGR5) is implicated in cancer stem cell biology.
- LGR5 is a Wnt signaling target and a prognostic biomarker in other cancers.
Purpose of the Study:
- To systematically review the role of LGR5 in prostate cancer progression.
- To elucidate the connection between LGR5 and associated signaling pathways.
- To identify LGR5-targeting strategies for improved prostate cancer treatment.
Main Methods:
- Systematic literature review.
- Analysis of molecular mechanisms involving LGR5.
- Examination of signaling pathways in prostate cancer.
Main Results:
- LGR5 expression is linked to cancer stem cells and prostate cancer progression.
- LGR5 influences cell proliferation, differentiation, and signaling.
- LGR5 gene alterations can drive treatment resistance.
Conclusions:
- LGR5 is a potential therapeutic target in prostate cancer.
- Understanding LGR5's molecular functions is crucial for developing novel therapies.
- Targeting LGR5 may overcome treatment resistance in prostate cancer.
